(Q37761076)

22 August 2017

1 reference

title

Altering the balance between healthy and mutated mitochondrial DNA. (English)

1 reference

22 August 2017

0 references

1 reference

Paul M Smith

1

1 reference

22 August 2017

Robert N Lightowlers

series ordinal

2

1 reference

22 August 2017

publication date

27 May 2010

1 reference

Journal of Inherited Metabolic Disease

22 August 2017

published in

1 reference

22 August 2017

volume

34

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

309-313

1 reference

https://scigraph.springernature.com/pub.10.1007/s10545-010-9122-6

22 August 2017

exact match

0 references

cites work

Sequence and organization of the human mitochondrial genome

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Peptide nucleic acid delivery to human mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Reversal of a mitochondrial DNA defect in human skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Expression of the alternative oxidase complements cytochrome c oxidase deficiency in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Mitochondrial disease--its impact, etiology, and pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Resistance training in patients with single, large-scale deletions of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Synthesis of trifunctional PNA-benzophenone derivatives for mitochondrial targeting, selective DNA binding, and photo-cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Strategies for treating disorders of the mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Preferential amplification and phenotypic selection in a population of deleted and wild-type mitochondrial DNA in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Gene shifting: a novel therapy for mitochondrial myopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9122-6

Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.

21 January 2018

1 reference

12 December 2020

Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects

1 reference

12 December 2020

Modulating mtDNA heteroplasmy by mitochondria-targeted restriction endonucleases in a 'differential multiple cleavage-site' model

1 reference

12 December 2020

The epidemiology of pathogenic mitochondrial DNA mutations

1 reference

12 December 2020

Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria

1 reference

12 December 2020

10.1007/S10545-010-9122-6

Identifiers

DOI

1 reference

22 August 2017

1 reference